Category: 13. Heart Failure: Therapy Background: Diabetes after heart transplantation is very common due to preexisting diabetes and diabetogenic anti-rejection medications such as the calcineurin inhibitors and corticosteroids. From various registries, diabetes has been found to be a risk factor for the development of transplant coronary artery disease (TCAD) and mortality after HTx. In the non-transplant population it has been suggested that better diabetic control (maintaining HbA1c<6) may result in less development of native CAD. The effect of strict diabetic control on the development of CAV in heart transplant patients has not been established.
